"label","uuid:ID","name","description","instanceType","text","id"
"","7fa464ad-440d-4fe9-8148-f3955ac554dd","OBJ1","Main objective","Objective","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Objective_1"
"","0df3deca-9da0-4882-8804-6572baccc0cc","OBJ2","Safety","Objective","To document the safety profile of the xanomeline TTS.","Objective_2"
"","2df14f3b-0f73-4cd7-b5db-9b9428856547","OBJ3","Behaviour","Objective","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Objective_3"
